Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Nano-Check Influenza+COVID-19 Dual Test

K-Number: K243561 · 2025-06-17

Decision Date2025-06-17
Product CodeSCA
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Nano-Check Influenza+COVID-19 Dual Test is the device name listed in this FDA 510(k) record. The listed applicant is Nano-Ditech Corporation. It received FDA 510(k) clearance on 2025-06-17 under 510(k) number K243561. The device is classified under product code SCA. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Nano-Check Influenza+COVID-19 Dual Test?

Nano-Check Influenza+COVID-19 Dual Test is a medical device that received FDA 510(k) clearance on 2025-06-17. The listed applicant is Nano-Ditech Corporation. The 510(k) number is K243561.

When did Nano-Check Influenza+COVID-19 Dual Test receive FDA 510(k) clearance?

Nano-Check Influenza+COVID-19 Dual Test received FDA 510(k) clearance on 2025-06-17, under 510(k) number K243561.

Who is the listed applicant for Nano-Check Influenza+COVID-19 Dual Test?

The FDA 510(k) record lists Nano-Ditech Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Nano-Check Influenza+COVID-19 Dual Test?

The FDA product code for Nano-Check Influenza+COVID-19 Dual Test is SCA.

Other records listing Nano-Ditech Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: SCA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.